BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Down 94.6% in June

BioSyent Inc. (OTCMKTS:BIOYF) saw a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 200 shares, a drop of 94.6% from the May 31st total of 3,700 shares. Based on an average daily volume of 2,100 shares, the short-interest ratio is currently 0.1 days.

BioSyent Stock Performance

Shares of OTCMKTS:BIOYF traded up $0.12 during midday trading on Thursday, hitting $7.62. 1,250 shares of the company’s stock traded hands, compared to its average volume of 2,621. The firm’s fifty day moving average price is $6.62 and its two-hundred day moving average price is $6.50. BioSyent has a twelve month low of $5.49 and a twelve month high of $7.76.

BioSyent Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Saturday, June 15th. Shareholders of record on Monday, June 3rd were issued a dividend of $0.0331 per share. The ex-dividend date of this dividend was Friday, May 31st. This represents a yield of 2.02%.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.